BioCentury
ARTICLE | Clinical News

Remicade infliximab regulatory update

August 30, 2004 7:00 AM UTC

JNJ subsidiary Centocor Inc. (Malvern, Penn.) issued a "dear healthcare provider" letter and updated the label for Remicade to warn of an increased risk of hematologic and neurologic events. Remicade...